Danske Invest MediLife Fund G Style and theme equity funds
Da nske Invest MediLife Fund G St yle and theme equit y funds
Risk class Fund Low risk
High risk
Fund facts Value 31-05-2011 (EUR) 0.60312 ISIN FI0008802947 Distribution of income No Benchmark index MSCI Health Care TR -index Web site www.danskeinvest.fi Launch 16-08-2000 Total assets , million (EUR) 59.52 Base currency EUR Minimum subscription 500 EUR or 30 EUR/month
Subscription fee Redemption fee TER 2010 Management fee
Investment policy
Performance 31-05-2011
Danske Invest MediLife is a mutual fund whose assets are invested globally, mainly in publicly traded equities and equitylinked securities of health care companies. The fund focuses on companies in the pharmaceuticals industry and companies offering health care services. The funds assets can also be invested in the equities of biotechnology sector companies. The fund is suitable as a long-term investment for experienced investors who are seeking an investment alternative in the pharmaceutical and health care sector. The general global performance of health care companies is reflected in the value of the fund, which may fluctuate substantially. Due to its higher level of risk than in conventional mutual funds, the fund is recommended as a small part of a diversified investment portfolio. The recommended investment horizon in the fund is more than five years.
Benchmark index
1,00 % / 8 EUR 1,00 % / 8 EUR 1,95 % 1.95 %
Unofficial MSCI Health Care (TR) Index
Portfolio manager The funds asset manager is Allianz Global Investors Europe GmbH and the portfolio management has been delegated to RCM Capital Management LLC, which is a member of Allianz Group.
Major investments 31-05-2011 Issuer
Key f igures - 1 y 31-05-2011 Volatility (%) Sharpe Tracking error IR Alpha Beta Duration
14.398 0.68 5.672 0.112 -1.399 1.076 -
Fresenius Medical Care AG & Co. KgaA Allergan Inc. Cardinal Health Inc. Shire Ltd. Ord. Edwards Lifesciences Corp. St. Jude Medical Inc. UnitedHealth Group Inc. Express Scripts Inc. A Novartis (Regd) (CHF) Haz Holdings Inc. Other
%
4.27 % 4.13 % 4.08 % 3.75 % 3.66 % 3.48 % 3.41 % 3.13 % 3.08 % 2.87 % 64.14 %
Performance 31-05-2011 YTD 1 month 3 month 6 month 12 month 36 month Fund 9.26 4.84 6.31 11.93 10.20 27.54 Benchmark index 6.74 5.35 6.00 9.10 11.54 28.49
Start -4.58 -1.96
This Fund Review is not an invitation to subscribe or redeem Fund units. Even though the aim has been to give reliable information, Sampo Bank and Sampo Fund Management Ltd guarantees neither the completeness nor correctness of the information contained in this Fund review nor shall be held liable for any errors or omissions in the information contained therein. Past mutual fund performance is no guarantee of future returns. The return and interest expectations used in the review are not intended to be perceived as promises of future returns or interest. Investment always involves fluctuation in value the value of an investment may either rise or fall and customers are therefore at risk of losing assets invested in a mutual fund. There is no guarantee of actual returns or that the performance of the investment will be in accordance with the expected returns or always positive. Before making an investment decision, customers should always familiarise themselves with the characteristics, expenses and risks of the mutual funds which are outlined in the simplified prospectuses, fund regulations and price list of mutual funds, for example. Funds simplified prospectus and regulations can be found from www.danskeinvest.fi
Da nske Invest MediLife Fund G St yle and theme equit y funds
Country allocation
Portfolio manager review nUnited States 66.31% nGermany 8.31% nUnited Kingdom 4.67% nSwitzerland 4.66% nFinland 3.17% nCayman Islands 2.25% nCanada 1.71% nOther 8.92%
Currency nUSD 72.39% nEUR 13.81% nGBP 4.67% nCHF 4.66% nNOK 1.47% nDKK 1.43% nHKD 0.80% nOther 0.77%
Holding type nStock market 96.83% nOther 3.17%
Return
Return and dividends for individual years
2006
2007
2008
2009
2010
Fund Benchmark index
-5.09 -0.39
-4.62 -6.50
-25.28 -16.66
14.22 15.86
16.23 10.83
This Fund Review is not an invitation to subscribe or redeem Fund units. Even though the aim has been to give reliable information, Sampo Bank and Sampo Fund Management Ltd guarantees neither the completeness nor correctness of the information contained in this Fund review nor shall be held liable for any errors or omissions in the information contained therein. Past mutual fund performance is no guarantee of future returns. The return and interest expectations used in the review are not intended to be perceived as promises of future returns or interest. Investment always involves fluctuation in value the value of an investment may either rise or fall and customers are therefore at risk of losing assets invested in a mutual fund. There is no guarantee of actual returns or that the performance of the investment will be in accordance with the expected returns or always positive. Before making an investment decision, customers should always familiarise themselves with the characteristics, expenses and risks of the mutual funds which are outlined in the simplified prospectuses, fund regulations and price list of mutual funds, for example. Funds
Risk class Fund Low risk
High risk
Fund facts Value 31-05-2011 (EUR) 0.60312 ISIN FI0008802947 Distribution of income No Benchmark index MSCI Health Care TR -index Web site www.danskeinvest.fi Launch 16-08-2000 Total assets , million (EUR) 59.52 Base currency EUR Minimum subscription 500 EUR or 30 EUR/month
Subscription fee Redemption fee TER 2010 Management fee
Investment policy
Performance 31-05-2011
Danske Invest MediLife is a mutual fund whose assets are invested globally, mainly in publicly traded equities and equitylinked securities of health care companies. The fund focuses on companies in the pharmaceuticals industry and companies offering health care services. The funds assets can also be invested in the equities of biotechnology sector companies. The fund is suitable as a long-term investment for experienced investors who are seeking an investment alternative in the pharmaceutical and health care sector. The general global performance of health care companies is reflected in the value of the fund, which may fluctuate substantially. Due to its higher level of risk than in conventional mutual funds, the fund is recommended as a small part of a diversified investment portfolio. The recommended investment horizon in the fund is more than five years.
Benchmark index
1,00 % / 8 EUR 1,00 % / 8 EUR 1,95 % 1.95 %
Unofficial MSCI Health Care (TR) Index
Portfolio manager The funds asset manager is Allianz Global Investors Europe GmbH and the portfolio management has been delegated to RCM Capital Management LLC, which is a member of Allianz Group.
Major investments 31-05-2011 Issuer
Key f igures - 1 y 31-05-2011 Volatility (%) Sharpe Tracking error IR Alpha Beta Duration
14.398 0.68 5.672 0.112 -1.399 1.076 -
Fresenius Medical Care AG & Co. KgaA Allergan Inc. Cardinal Health Inc. Shire Ltd. Ord. Edwards Lifesciences Corp. St. Jude Medical Inc. UnitedHealth Group Inc. Express Scripts Inc. A Novartis (Regd) (CHF) Haz Holdings Inc. Other
%
4.27 % 4.13 % 4.08 % 3.75 % 3.66 % 3.48 % 3.41 % 3.13 % 3.08 % 2.87 % 64.14 %
Performance 31-05-2011 YTD 1 month 3 month 6 month 12 month 36 month Fund 9.26 4.84 6.31 11.93 10.20 27.54 Benchmark index 6.74 5.35 6.00 9.10 11.54 28.49
Start -4.58 -1.96
This Fund Review is not an invitation to subscribe or redeem Fund units. Even though the aim has been to give reliable information, Sampo Bank and Sampo Fund Management Ltd guarantees neither the completeness nor correctness of the information contained in this Fund review nor shall be held liable for any errors or omissions in the information contained therein. Past mutual fund performance is no guarantee of future returns. The return and interest expectations used in the review are not intended to be perceived as promises of future returns or interest. Investment always involves fluctuation in value the value of an investment may either rise or fall and customers are therefore at risk of losing assets invested in a mutual fund. There is no guarantee of actual returns or that the performance of the investment will be in accordance with the expected returns or always positive. Before making an investment decision, customers should always familiarise themselves with the characteristics, expenses and risks of the mutual funds which are outlined in the simplified prospectuses, fund regulations and price list of mutual funds, for example. Funds simplified prospectus and regulations can be found from www.danskeinvest.fi
Da nske Invest MediLife Fund G St yle and theme equit y funds
Country allocation
Portfolio manager review nUnited States 66.31% nGermany 8.31% nUnited Kingdom 4.67% nSwitzerland 4.66% nFinland 3.17% nCayman Islands 2.25% nCanada 1.71% nOther 8.92%
Currency nUSD 72.39% nEUR 13.81% nGBP 4.67% nCHF 4.66% nNOK 1.47% nDKK 1.43% nHKD 0.80% nOther 0.77%
Holding type nStock market 96.83% nOther 3.17%
Return
Return and dividends for individual years
2006
2007
2008
2009
2010
Fund Benchmark index
-5.09 -0.39
-4.62 -6.50
-25.28 -16.66
14.22 15.86
16.23 10.83
This Fund Review is not an invitation to subscribe or redeem Fund units. Even though the aim has been to give reliable information, Sampo Bank and Sampo Fund Management Ltd guarantees neither the completeness nor correctness of the information contained in this Fund review nor shall be held liable for any errors or omissions in the information contained therein. Past mutual fund performance is no guarantee of future returns. The return and interest expectations used in the review are not intended to be perceived as promises of future returns or interest. Investment always involves fluctuation in value the value of an investment may either rise or fall and customers are therefore at risk of losing assets invested in a mutual fund. There is no guarantee of actual returns or that the performance of the investment will be in accordance with the expected returns or always positive. Before making an investment decision, customers should always familiarise themselves with the characteristics, expenses and risks of the mutual funds which are outlined in the simplified prospectuses, fund regulations and price list of mutual funds, for example. Funds
